Yes, fibronectin has potential as a biomarker for certain types of cancer. Elevated levels of fibronectin have been detected in the plasma and tissues of patients with various cancers, including breast, lung, and colorectal cancers. Monitoring fibronectin levels can help in the diagnosis and prognosis of cancer, as well as in assessing the effectiveness of treatments.
